Pfizer Inc (NYSE: PFE) and Medivation, Inc.(NASDAQ: MDVN) entered into an agreement to develop and commercialize Dimebon, Medivation's investigational drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE